BioWorld

March 23, 1998

View Archived Issues

Transcend Halts Phase III Trial; Stock Plummets 61 Percent

Read More

PharmaPrint Trying To Put Botanicals On Par With Drugs

Read More

Switching To Bacterial Host Cells Eases Adenovirus Production

Read More

Appointments And Advancements

Read More

Other News To Note

Read More

Ribozyme, Parke-Davis Sign Gene Targeting Agreement

Read More

Brain Cells' Axonal Architect Moonlights As Blood-Vessel Patterning Design Engin

Read More